Thoracoscopic Sympathectomy for Blushing

NCT ID: NCT00225069

Last Updated: 2012-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-09-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To determine the outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing. In addition, following randomization investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. Includes QoL before and 12 months after surgery

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Facial Blushing

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Facial blushing Sympathectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

T2 sympathectomy

Group Type EXPERIMENTAL

Level of sympathectomy

Intervention Type PROCEDURE

T2 sympathectomy or T2-T3 sympathectomy

2

T2-T3 sympathectomy

Group Type EXPERIMENTAL

Level of sympathectomy

Intervention Type PROCEDURE

T2 sympathectomy or T2-T3 sympathectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Level of sympathectomy

T2 sympathectomy or T2-T3 sympathectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Isolated disabling facial blushing
* Over 18 years of age
* Willing to be randomized

Exclusion Criteria

* Primary hyperhidrosis in palms or axillae
* Previous lung surgery
* Bradycardia
* Arrythmias
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aarhus University Hospital

OTHER

Sponsor Role collaborator

Odense University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter B Licht

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter B Licht, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Odense University Hospital

Hans K Pilegaard, MD

Role: STUDY_CHAIR

Skejby Sygehus, Aarhus University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept Cardiothoracic Surgery, Skejby Sygehus, Aarhus University Hospital

Aarhus, , Denmark

Site Status

Dept Cardiothorcic Surgery, Odense University Hospital

Odense, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TOPSY1-2005

Identifier Type: -

Identifier Source: org_study_id